Immunogenicity and safety of a 12-valent pneumococcal conjugate vaccine in infants aged 6-10 weeks: a randomized double-blind active-controlled trial

• Main Authors: Jonghoon Shin (Author), Jamaree Teeratakulpisarn (Author), Thanyawee Puthanakit (Author), Tuangtip Theerawit (Author), Ji Hwa Ryu (Author), Jinhwan Shin (Author), Seulgi Lee (Author), Hayoung Lee (Author), Kyungjun An (Author), Hun Kim (Author)
• Format: Book
• Published: The Korean Pediatric Society, 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Pneumococcal diseases among children aged <5 years worldwide are associated with high annual mortality rates. Purpose This study aimed to evaluate the immunogenicity and safety of GBP411, a 12-valent pneumococcal conjugant vaccine, with a dosing schedule of 2 primary doses plus 1 boost...